Skip to main content
. 2022 Mar 21;21(1):e12453. doi: 10.1002/rmb2.12453

TABLE 2.

Characteristics of cryopreservation for childhood, adolescent, and young adult patients with breast cancer and hematologic malignancy

Institutions, n Patients, n Number of patients per institution, median (range)

Patient age at cryopreservation, years,

mean ± SD (range)

Pre Post Pre Post Pre Post Pre Post
Breast cancer 72 116 760 1535 4 (1–127) 6 (1–139) 35.5 ± 3.52 (20–48) 35.2 ± 2.56 (17–50)
Hematologic malignancy 50 73 216 393 2 (1–66) 3 (1–37) 27.0 ± 5.86 (5–42) 27.0 ± 5.17 (11–45)

Pre, 2011–2015, i.e., before publication of the Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer Patients 8 , 9 ; post, 2016–2019, i.e., from shortly before to after publication of the guidelines.